Carmignac Gestion acquired a new position in shares of Monsanto Co. (NYSE:MON) during the second quarter, according to its most recent disclosure with the SEC. The firm acquired 1,910,408 shares of the company’s stock, valued at approximately $197,555,000. Monsanto accounts for about 1.7% of Carmignac Gestion’s portfolio, making the stock its 24th largest position.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new stake in Monsanto during the second quarter worth about $383,000. Tokio Marine Asset Management Co. Ltd. boosted its stake in shares of Monsanto by 0.7% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 22,335 shares of the company’s stock worth $2,310,000 after buying an additional 150 shares in the last quarter. Bartlett & Co. LLC boosted its stake in shares of Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock worth $145,000 after buying an additional 134 shares in the last quarter. Paradigm Financial Advisors LLC boosted its stake in shares of Monsanto by 10.5% in the second quarter. Paradigm Financial Advisors LLC now owns 5,837 shares of the company’s stock worth $603,000 after buying an additional 554 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. bought a new stake in shares of Monsanto during the second quarter worth $12,767,000. 79.06% of the stock is owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded down 0.75% on Thursday, reaching $101.79. The company’s stock had a trading volume of 2,670,298 shares. The firm’s 50 day moving average is $105.35 and its 200-day moving average is $100.92. Monsanto Co. has a 12 month low of $83.73 and a 12 month high of $114.26. The firm has a market cap of $44.54 billion, a P/E ratio of 44.80 and a beta of 1.24.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.40 by $0.23. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The business had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.49 billion. During the same period in the prior year, the business posted $2.39 earnings per share. The firm’s revenue for the quarter was down 8.5% compared to the same quarter last year. On average, equities research analysts anticipate that Monsanto Co. will post $4.46 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.12%. Monsanto’s dividend payout ratio is presently 89.26%.
A number of analysts have weighed in on the company. Deutsche Bank AG reaffirmed a “buy” rating and issued a $100.00 price target on shares of Monsanto in a research report on Wednesday, June 1st. S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Monsanto in a research report on Thursday, June 30th. Zacks Investment Research cut Monsanto from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Finally, Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price target for the company in a research report on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto has a consensus rating of “Buy” and an average target price of $114.31.
In other news, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.